GRIDION™ MK1 OXFORD NANPORE CAPITAL AWARD

Concepts

• oxford nanopore technologies
• cardiff
• medical equipment
• oxford nanopore
• mk1 oxford nanpore capital award
• oxford
• main description of this notice
• public health england national microbiology
• further details
• asynchronous sequencing ports

Location

Cardiff and Vale of Glamorgan:

Description

NWSSP on behalf of Cardiff and Value UHB have been requested to purchase a GRIDION™ MK1 from Oxford Nanopore Technologies. Oxford Nanopore is listed as a supplier on Public Health England National Microbiology Framework Lot 1. The framework allows for direct award on technical justification. Further details within the main description of this notice

Total Quantity or Scope

This notice is to confirm a contract has been awarded with Oxford Nanopore Technologies for the purchase of the GridION™ Mk1. The contract will be direct awarded on technical grounds via Public Health England National Microbiology Framework Lot 1. This notice is to be taken as the 10 day standstill period and will expire on the 11th March at midnight. If you have any questions regarding this notice please contact us through sell to wales. Patents held by Oxford Nanopore Technologies in Europe and the United States, GridION Mk1 cannot be offered by other companies. The equipment has the below unique features: - - 5 asynchronous sequencing ports allowing flexibility for sequencing runs. - Compatible with both MinION and Flongle flow cells, providing the option to go for a low or higher throughput sequencing run - A benchtop instrument with built in GPU capacity for real-time basecalling and analysis - Adaptive sampling capability, allowing for customisable computational target enrichment, with the same workflow - Nanopore sequencing has unrestricted read length, allowing for both short and long reads to be generated on the platform Exclusivity for component used in Nanopore Detection Technology provided by Oxford Nanopore Technologies, as well as for methods performed by the same technology, is considered exclusive to the company and is protected by one or more of the following patents, owned or exclusively licensed to the company: - WO2010/086622 - US5795782A1 - WO2012/164270 - US6015714A1 - WO2013/014451 - US6362002B1 - WO2014/013260 - EP1238275B1 - WO2013/041878 - US8673556B2 - WO2010/000789

Award Detail

Renewal Options

Following a Prior Information Notice which expired on the 11th March 2022 with no challenges an award has now been made to oxford nanopore.

Award Criteria

CPV Codes

• 33100000 - Medical equipments

Indicators

• Options are available.

Legal Justification

As per the description there are patents present on the equipment which has prevent competition from other suppliers.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** (WA Ref:119819)